Our top pick for
LGI Homes Inc is a residential construction business based in the US. LGI Homes shares (LGIH) are listed on the NASDAQ and all prices are listed in US Dollars. LGI Homes employs 938 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$145.26|
|52-week range||$95.54 - $188.00|
|50-day moving average||$149.36|
|200-day moving average||$159.83|
|Wall St. target price||$142.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$17.54|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-13)||2.35%|
|1 month (2021-09-22)||-4.21%|
|3 months (2021-07-22)||-9.96%|
|6 months (2021-04-22)||-11.94%|
|1 year (2020-10-22)||29.38%|
|2 years (2019-10-22)||74.47%|
|3 years (2018-10-22)||284.90%|
|5 years (2016-10-21)||349.03%|
Valuing LGI Homes stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LGI Homes's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
LGI Homes's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, LGI Homes shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
LGI Homes's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.69. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into LGI Homes's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
LGI Homes's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $517.6 million.
The EBITDA is a measure of a LGI Homes's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$2.9 billion|
|Operating margin TTM||17.64%|
|Gross profit TTM||$608 million|
|Return on assets TTM||17.48%|
|Return on equity TTM||40.2%|
|Market capitalisation||$3.4 billion|
TTM: trailing 12 months
There are currently 2.2 million LGI Homes shares held short by investors – that's known as LGI Homes's "short interest". This figure is 6.5% up from 2.0 million last month.
There are a few different ways that this level of interest in shorting LGI Homes shares can be evaluated.
LGI Homes's "short interest ratio" (SIR) is the quantity of LGI Homes shares currently shorted divided by the average quantity of LGI Homes shares traded daily (recently around 185014.29794521). LGI Homes's SIR currently stands at 11.68. In other words for every 100,000 LGI Homes shares traded daily on the market, roughly 11680 shares are currently held short.
However LGI Homes's short interest can also be evaluated against the total number of LGI Homes shares, or, against the total number of tradable LGI Homes shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case LGI Homes's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 LGI Homes shares in existence, roughly 90 shares are currently held short) or 0.0995% of the tradable shares (for every 100,000 tradable LGI Homes shares, roughly 100 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against LGI Homes.
Find out more about how you can short LGI Homes stock.
We're not expecting LGI Homes to pay a dividend over the next 12 months.
Over the last 12 months, LGI Homes's shares have ranged in value from as little as $95.54 up to $188. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while LGI Homes's is 1.5894. This would suggest that LGI Homes's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
LGI Homes, Inc. designs, constructs, and sells homes in the United States. It offers entry-level homes, such as detached and attached homes, and move-up homes under the LGI Homes brand name; and luxury series homes under the Terrata Homes brand name. As of December 31, 2020, it owned 113 communities. The company serves in Texas, Arizona, Florida, Georgia, New Mexico, Colorado, North Carolina, South Carolina, Washington, Tennessee, Minnesota, Oklahoma, Alabama, California, Oregon, Nevada, West Virginia, Virginia, and Pennsylvania. LGI Homes, Inc. was founded in 2003 and is headquartered in The Woodlands, Texas.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.